Authors
Latest:
Chronic Obstructive Pulmonary Disease: Diagnosis and TreatmentChronic obstructive pulmonary disease is a leading cause of morbidity and mortality and a considerable drain on health care resources in the industrialized world. In some patients the disease is inherited, but the vast majority of cases are caused by cigarette smoking. Recognizing the signs and symptoms and understanding the disease progression will facilitate a timely diagnosis. Although the disease is incurable, encouraging patients to stop smoking and providing supplemental oxygen can enhance survival. Significant advances in management as outlined by the authors notwithstanding, efforts to reduce the prevalence of cigarette smoking hold the most promise for reducing the disease burden and associated costs.
Latest:
Talk Doesn't Come CheapAre psychiatrists really money-hungry, unfeeling, uncaring, sociopaths?
Latest:
CMS Denying Payments for Many Preventable Errors-August 2008Nosocomial infections and hypoglycemia/hyperglycemia have been added to the agency's list of problems that should never occur and whose resolution will not be covered.
Latest:
Calcium Density of Coronary Artery Plaque and Risk of Incident Cardiovascular EventsThe Multi-Ethnic Study of Atherosclerosis study examined the association of coronary artery calcium volume and density with incident cardiovascular events.
Latest:
Clinical Pearls for RA ManagementNehad Soloman, MD; Joy Schechtman, DO; and Robert Levin, MD, share final thoughts and takeaways on the treatment of rheumatoid arthritis in the community setting.
Latest:
Underlying Personality Disorders Can Complicate Chronic Pain ManagementUnderstanding and addressing these disorders can improve the patient's mental health as well as their chronic pain and other comorbid conditions. Incorporating cognitive behavioral therapy and mindfulness-based cognitive therapy into the management of chronic pain has been shown to improve pain outcomes.
Latest:
What Clinicians Need to Know about Ebola Hemorrhagic FeverInfectious disease specialist discusses the intricacies of the deadly virus
Latest:
Sex differences in the development of higher systolic blood pressure during adolescenceWe evaluated the differences in higher systolic blood pressure (SBP) between boys and girls in a longitudinal adolescent cohort. Results showed that although boys have a 19% relative increase in the risk of higher SBP annually between the ages of 13 and 17 years, girls do not experience the same risk increase. Among both boys and girls, being overweight increases the likelihood of high SBP almost 3-fold, and every 5 additional hours of "screen time" (television viewing, video game playing, Internet use) is associated with a 4% relative increase in the likelihood of higher SBP levels. For every 5 additional sports-related or other active behaviors over a 7-day recall, there was an 8% relative reduction in high SBP risk. Annual blood pressure assessment in teens that continues into adulthood may facilitate early detection of adult hypertension. Weight control, increased physical activity, and reduced screen time may reduce the likelihood of higher SBP levels developing in adolescents.
Latest:
How Population Rates Dictate the Geriatric Healthcare MarketIncreasing life expectancy from improved healthcare has directly influenced the avenues by which elderly people seek aid and care.
Latest:
What Should I Prescribe for This Man's Depression?Several factors should be considered when choosing a medication and dosing schedule for this depressed adult male who reports being "very sensitive" to medication and expresses particular concern about being either sedated or "revved up" from an antidepressant.
Latest:
Developing Long-Term and Effective Collaborations with Patient Advocacy GroupsWhen successful, these relationships provide valuable insights to support strategies in many areas, including planning for clinical research, patient recruitment and education, reimbursement, access, compliance, and other areas.
Latest:
Anti-inflammatory effects of pioglitazone and/or simvastatin in patients with distinct clinical risk for cardiovascular complicationsStatins are the most commonly used pharmacologic intervention in patients with increased cardiovascular risk. In addition to their beneficial effect on the atherogenic lipid profile, they have been shown to exert several pleiotrophic effects, including the reduction of low-grade inflammation. Thiazolidinediones (TZDs) are a new class of antidiabetic drugs that have been shown to improve insulin sensitivity and to reduce cardiovascular risk in patients with type 2 diabetes. Our study is the first to show a complementary effect of TZD and statin treatment on several cardiovascular risk factors in subjects without diabetes. These findings may have important implications for further discussion on cardiovascular risk reduction, especially for patients with metabolic syndrome.
Latest:
Sudden death in patients with myocardial infarctionWe evaluated the risk and timing of sudden death among high-risk patients after myocardial infarction (MI). Among survivors of acute MI with reduced left ventricular systolic function or heart failure, or both, the risk of sudden death from cardiac causes was highest in the first 30 days after MI. These findings indicate a need for early intervention to prevent sudden death during this vulnerable period.
Latest:
Top 5 Rare Disease News of the Week—September 23, 2018Stay up-to-date on the latest rare disease news by reading the top 5 articles of the week.
Latest:
Smoother Care Transitions Cut Readmissions for OPAT PatientsReadmission reduction has the potential for broad impact, especially in disadvantaged populations.
